Ranbaxy Laboratories to be Acquired by Sun Pharmaceutical Industries Ltd in Late 2014

Font size AAA
11 Apr 2014 09:43 Helen Clark

CHEMMONITOR.COM – Sun Pharmaceutical Industries Ltd (India) intends to acquire Ranbaxy Laboratories (India) for USD 3.2 billion. The acquisition will create the largest generic drug business in India with profit of USD 4.2 billion. Moreover, the combined business will offer a strong portfolio of generic and specialty materials. The overall value of the purchase, including Ranbaxy Laboratories debt, will total USD 4 billion.

03 Feb
Arlanxeo to Start Chloroprene Rubber Capacity Expansion in Q2 2018
03 Feb
Nippon Shokubai to Raise Production Capacities at Three Plants
03 Feb
Grupo Antolín Irausa to Build Three New Plants in the USA
26 Jan
SK Global Chemical Shuts No. 2 Naphtha Cracker in Ulsan
26 Jan
Perlen Packaging to Purchase Stake in Sekoya Indústria e Comércio